SAERA: Advanced Education and e-Learning

By Kevin Patrick Barman, Psychotherapist and Master in Applied Neuroscience student.

Abstract

This paper aims to examine theories that attempt to explain biochemical changes in the brain as well as the metabolism of individuals who experience symptoms and conditions related to neurological disorders like depression, Alzheimer’s disease, Parkinson’s disease, metabolite syndrome, and cardiovascular diseases. A systematic literature search was performed on NCBI and PubMed. The search included the keywords neurological disorders, monoamine hypothesis, metabolic syndrome, oxytocin receptor, dietary health, and magnesium intake. Excluding those that did not involve symptoms of neurological disorders. Twenty-six research articles met the criteria for the literature review of this examination. In particular, this paper will review multiple studies that investigate the monoamine (MAO) hypothesis of depression and metabolic syndrome (MetS) as a risk factor for neurological disorders. While studies that evaluate additional risk factors for neurological disorders, such like autoimmunity and rheumatic diseases, oxytocin receptor (OXTR) DNA methylation in postpartum depression, dietary health in children and their psychological health, and dietary magnesium and cardiovascular disease, will be reviewed as well.

Keywords: neurological disorders, monoamine hypothesis, metabolic syndrome, oxytocin receptor, dietary health, magnesium intake and cardiovascular disease, will be reviewed as well.

Download the full Research Work: Kevin Patrick Barman (2022). Biochemical Changes in the Brain and Metabolism as Risk Factors of Neurological Disorders. SAERA

 

Leave a Reply

Your email address will not be published. Required fields are marked *